COCP Annual CFO
-$14.67 M
+$6.77 M+31.58%
31 December 2023
Summary:
As of January 23, 2025, COCP annual cash flow from operations is -$14.67 million, with the most recent change of +$6.77 million (+31.58%) on December 31, 2023. During the last 3 years, it has fallen by -$4.84 million (-49.20%). COCP annual CFO is now -58330.28% below its all-time high of -$25.10 thousand, reached on December 31, 2009.COCP Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
COCP Quarterly CFO
-$5.12 M
-$1.42 M-38.50%
30 September 2024
Summary:
As of January 23, 2025, COCP quarterly cash flow from operations is -$5.12 million, with the most recent change of -$1.42 million (-38.50%) on September 30, 2024. Over the past year, it has dropped by -$2.44 million (-91.09%). COCP quarterly CFO is now -353.87% below its all-time high of $2.02 million, reached on March 31, 2019.COCP Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
COCP TTM CFO
-$16.65 M
-$2.44 M-17.19%
30 September 2024
Summary:
As of January 23, 2025, COCP TTM cash flow from operations is -$16.65 million, with the most recent change of -$2.44 million (-17.19%) on September 30, 2024. Over the past year, it has dropped by -$418.00 thousand (-2.58%). COCP TTM CFO is now -19922.62% below its all-time high of $84.00 thousand, reached on September 30, 2011.COCP TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
COCP Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.6% | -91.1% | -2.6% |
| 3 y3 years | -49.2% | -4.7% | +22.3% |
| 5 y5 years | -76.9% | -4.7% | +22.3% |
COCP Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -15.3% | +31.6% | -91.1% | +42.5% | -30.9% | +25.9% |
| 5 y | 5-year | -838.3% | +31.6% | -316.5% | +42.5% | -965.3% | +25.9% |
| alltime | all time | <-9999.0% | +31.6% | -353.9% | +42.5% | <-9999.0% | +25.9% |
Cocrystal Pharma Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.12 M(+38.5%) | -$16.65 M(+17.2%) |
| June 2024 | - | -$3.70 M(-17.9%) | -$14.21 M(-11.5%) |
| Mar 2024 | - | -$4.50 M(+35.4%) | -$16.06 M(+9.5%) |
| Dec 2023 | -$14.67 M(-31.6%) | -$3.33 M(+24.1%) | -$14.67 M(-9.7%) |
| Sept 2023 | - | -$2.68 M(-51.7%) | -$16.23 M(-27.7%) |
| June 2023 | - | -$5.55 M(+78.3%) | -$22.46 M(+8.8%) |
| Mar 2023 | - | -$3.11 M(-36.4%) | -$20.64 M(-3.7%) |
| Dec 2022 | -$21.43 M(+68.5%) | -$4.89 M(-45.1%) | -$21.43 M(+10.1%) |
| Sept 2022 | - | -$8.91 M(+139.2%) | -$19.46 M(+22.0%) |
| June 2022 | - | -$3.72 M(-4.8%) | -$15.96 M(+7.4%) |
| Mar 2022 | - | -$3.91 M(+33.8%) | -$14.86 M(+16.8%) |
| Dec 2021 | -$12.72 M(+29.4%) | -$2.92 M(-45.9%) | -$12.72 M(+4.4%) |
| Sept 2021 | - | -$5.40 M(+105.9%) | -$12.18 M(+23.8%) |
| June 2021 | - | -$2.62 M(+48.2%) | -$9.84 M(+4.5%) |
| Mar 2021 | - | -$1.77 M(-25.7%) | -$9.41 M(-4.3%) |
| Dec 2020 | -$9.83 M(+528.9%) | -$2.38 M(-22.2%) | -$9.83 M(+13.3%) |
| Sept 2020 | - | -$3.06 M(+39.1%) | -$8.68 M(+25.0%) |
| June 2020 | - | -$2.20 M(+0.5%) | -$6.94 M(+20.3%) |
| Mar 2020 | - | -$2.19 M(+77.9%) | -$5.77 M(+269.1%) |
| Dec 2019 | -$1.56 M(-81.1%) | -$1.23 M(-7.0%) | -$1.56 M(-32.1%) |
| Sept 2019 | - | -$1.32 M(+28.7%) | -$2.30 M(-26.4%) |
| June 2019 | - | -$1.03 M(-150.9%) | -$3.13 M(-25.4%) |
| Mar 2019 | - | $2.02 M(-202.4%) | -$4.19 M(-49.4%) |
| Dec 2018 | -$8.29 M(+20.1%) | -$1.97 M(-8.3%) | -$8.29 M(+4.9%) |
| Sept 2018 | - | -$2.15 M(+2.7%) | -$7.90 M(-0.5%) |
| June 2018 | - | -$2.09 M(+0.7%) | -$7.94 M(+14.5%) |
| Mar 2018 | - | -$2.08 M(+31.5%) | -$6.93 M(+0.4%) |
| Dec 2017 | -$6.90 M(-52.9%) | -$1.58 M(-27.7%) | -$6.90 M(-9.5%) |
| Sept 2017 | - | -$2.19 M(+101.5%) | -$7.62 M(-11.2%) |
| June 2017 | - | -$1.08 M(-47.1%) | -$8.58 M(-32.2%) |
| Mar 2017 | - | -$2.05 M(-10.8%) | -$12.66 M(-13.6%) |
| Dec 2016 | -$14.65 M | -$2.30 M(-26.9%) | -$14.65 M(-4.8%) |
| Sept 2016 | - | -$3.15 M(-39.1%) | -$15.39 M(-0.3%) |
| June 2016 | - | -$5.17 M(+27.8%) | -$15.44 M(+20.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | -$4.04 M(+33.0%) | -$12.80 M(+24.1%) |
| Dec 2015 | -$10.32 M(+71.6%) | -$3.04 M(-4.6%) | -$10.32 M(+14.2%) |
| Sept 2015 | - | -$3.19 M(+25.9%) | -$9.03 M(+29.3%) |
| June 2015 | - | -$2.53 M(+62.3%) | -$6.98 M(+20.6%) |
| Mar 2015 | - | -$1.56 M(-11.2%) | -$5.79 M(-3.7%) |
| Dec 2014 | -$6.01 M(+63.1%) | -$1.75 M(+54.1%) | -$6.01 M(+18.7%) |
| Sept 2014 | - | -$1.14 M(-14.9%) | -$5.07 M(+3.9%) |
| June 2014 | - | -$1.34 M(-24.8%) | -$4.87 M(+8.0%) |
| Mar 2014 | - | -$1.78 M(+120.3%) | -$4.51 M(+22.5%) |
| Dec 2013 | -$3.69 M(+132.0%) | -$808.00 K(-14.8%) | -$3.69 M(+30.2%) |
| Sept 2013 | - | -$948.00 K(-3.1%) | -$2.83 M(+91.1%) |
| June 2013 | - | -$978.00 K(+2.7%) | -$1.48 M(+144.7%) |
| Mar 2013 | - | -$952.00 K(-2087.5%) | -$605.20 K(-61.9%) |
| Dec 2012 | -$1.59 M(+277.4%) | $47.90 K(-88.1%) | -$1.59 M(-21.2%) |
| Sept 2012 | - | $401.00 K(-492.8%) | -$2.02 M(+25.4%) |
| June 2012 | - | -$102.10 K(-94.7%) | -$1.61 M(-15.1%) |
| Mar 2012 | - | -$1.94 M(+409.4%) | -$1.89 M(+350.1%) |
| Dec 2011 | -$421.00 K(+61.1%) | -$380.00 K(-147.0%) | -$420.90 K(-601.1%) |
| Sept 2011 | - | $809.30 K(-308.6%) | $84.00 K(-113.1%) |
| June 2011 | - | -$388.00 K(-16.1%) | -$639.10 K(-10.9%) |
| Mar 2011 | - | -$462.20 K(-470.1%) | -$717.30 K(+174.4%) |
| Dec 2010 | -$261.40 K(+941.4%) | $124.90 K(+44.9%) | -$261.40 K(-32.9%) |
| Sept 2010 | - | $86.20 K(-118.5%) | -$389.40 K(-18.4%) |
| June 2010 | - | -$466.20 K(+7300.0%) | -$477.40 K(+2386.5%) |
| Mar 2010 | - | -$6300.00(+103.2%) | -$19.20 K(-23.8%) |
| Dec 2009 | -$25.10 K(-25.3%) | -$3100.00(+72.2%) | -$25.20 K(-6.0%) |
| Sept 2009 | - | -$1800.00(-77.5%) | -$26.80 K(-12.7%) |
| June 2009 | - | -$8000.00(-35.0%) | -$30.70 K(-4.1%) |
| Mar 2009 | - | -$12.30 K(+161.7%) | -$32.00 K(-4.8%) |
| Dec 2008 | -$33.60 K(-1.8%) | -$4700.00(-17.5%) | -$33.60 K(+16.3%) |
| Sept 2008 | - | -$5700.00(-38.7%) | -$28.90 K(+24.6%) |
| June 2008 | - | -$9300.00(-33.1%) | -$23.20 K(+66.9%) |
| Mar 2008 | - | -$13.90 K | -$13.90 K |
| Dec 2007 | -$34.20 K | - | - |
FAQ
- What is Cocrystal Pharma annual cash flow from operations?
- What is the all time high annual CFO for Cocrystal Pharma?
- What is Cocrystal Pharma annual CFO year-on-year change?
- What is Cocrystal Pharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for Cocrystal Pharma?
- What is Cocrystal Pharma quarterly CFO year-on-year change?
- What is Cocrystal Pharma TTM cash flow from operations?
- What is the all time high TTM CFO for Cocrystal Pharma?
- What is Cocrystal Pharma TTM CFO year-on-year change?
What is Cocrystal Pharma annual cash flow from operations?
The current annual CFO of COCP is -$14.67 M
What is the all time high annual CFO for Cocrystal Pharma?
Cocrystal Pharma all-time high annual cash flow from operations is -$25.10 K
What is Cocrystal Pharma annual CFO year-on-year change?
Over the past year, COCP annual cash flow from operations has changed by +$6.77 M (+31.58%)
What is Cocrystal Pharma quarterly cash flow from operations?
The current quarterly CFO of COCP is -$5.12 M
What is the all time high quarterly CFO for Cocrystal Pharma?
Cocrystal Pharma all-time high quarterly cash flow from operations is $2.02 M
What is Cocrystal Pharma quarterly CFO year-on-year change?
Over the past year, COCP quarterly cash flow from operations has changed by -$2.44 M (-91.09%)
What is Cocrystal Pharma TTM cash flow from operations?
The current TTM CFO of COCP is -$16.65 M
What is the all time high TTM CFO for Cocrystal Pharma?
Cocrystal Pharma all-time high TTM cash flow from operations is $84.00 K
What is Cocrystal Pharma TTM CFO year-on-year change?
Over the past year, COCP TTM cash flow from operations has changed by -$418.00 K (-2.58%)